Fra(X)(q27.2), the common fragile site, observed in only one of 760 cases studied for the fragile X syndrome.
Cell cultures from 760 whole blood, amniotic fluid, chorionic villus sample, and peripheral umbilical blood sample specimens were exposed to multiple fra(X)(q27.3) induction systems (none had aphidicolin). Fifty-three exhibited the rare fragile site, fra(X)(q27.3) or FRAXA, none of which demonstrated the common fragile site or FRAXD at band Xq27.2. Only one cell in one of the negative whole blood FUdR-treated cultures from a mentally retarded male showed FRAXD. Therefore, it appears that FRAXD occurs very rarely in cultures treated to induce FRAXA since only one positive cell was observed in over 88,000 analyzed. It appears that very low frequencies of fra(X)(q27) can be accounted for only in part by the presence of the common fragile site since only one of 9 cases, each with one fra(X)(q27) positive cell, exhibited FRAXD and the others were FRAXA. After confirmation of FRAXA with direct DNA testing in a large number of low frequency cases, it should be possible to rely on the detection of very low frequencies of fra(X)(q27.3), e.g., 1% with at least 2 positive cells.
Jenkins
E C
EC
Department of Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.
Genovese
M J
MJ
Duncan
C J
CJ
Gu
H
H
Stark-Houck
S L
SL
Lele
K
K
Li
S Y
SY
Krawczun
M S
MS
D000653:Amniotic Fluid / Q000166:cytology; D016590:Aphidicolin; D002824:Chorionic Villi / Q000648:ultrastructure; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D003582:Cytogenetics / Q000379:methods; D005260:Female; D005312:Fetal Blood / Q000166:cytology; D005600:Fragile X Syndrome / Q000175:diagnosis / Q000235:genetics*; D006801:Humans; D008297:Male; D011247:Pregnancy; D011296:Prenatal Diagnosis; D014960:X Chromosome
D016590:Aphidicolin